Clinical trials

  • MODIFIED MESSENGER RIBONUCLEIC ACID ENCODING HUMAN PROPIONYL-COENZYME A CARBOXYLASE ALPHA AND BETA SUBUNITS ENCAPSULATED INTO LIPID NANOPARTICLES for Propionic acidemia
  • DEXLANSOPRAZOLE for Nonerosive gastroesophageal reflux disease
  • EVOLOCUMAB for Healthy volunteers
  • DENGUE VIRUS, SEROTYPE 2, LIVE, ATTENUATED, DENGUE VIRUS, SEROTYPE 2, EXPRESSING DENGUE VIRUS, SEROTYPE 1, SURFACE PROTEINS, LIVE, ATTENUATED, DENGUE VIRUS, SEROTYPE 2, EXPRESSING DENGUE VIRUS, SEROTYPE 3, SURFACE PROTEINS, LIVE, ATTENUATED, DENGUE VIRUS, SEROTYPE 2, EXPRESSING DENGUE VIRUS, SEROTYPE 4, SURFACE PROTEINS, LIVE, ATTENUATED for Dengue fever
  • ozanimod hydrochloride for Relapsing-remitting multiple sclerosis
  • GENTAMICIN SULFATE for Congenital ichthyosis | Hereditary ichthyosis
  • TEPOTINIB for Non-small cell lung cancer (MET exon 14‑mutated)
  • ENTRECTINIB for Pediatric solid tumors | Primary central nervous system (CNS) tumors
  • DISITAMAB VEDOTIN for Urothelial carcinoma
  • Clinical trial in Short bowel syndrome|Bacterial infection
  • DF-006 for Chronic Hepatitis B
  • TARLATAMAB for Small cell lung cancer|Brain metastases